KSC Equity Snapshot

068270 Weekly Equity Report

Celltrion, Inc.

Latest Close 173,000 KRW 12 Jun 2026
1W Return 0.9% latest completed week
4W Return -3.8% short-term follow-through
12W Return -14.4% quarterly tape
Trend Breadth 63.5% 33 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
Company Brief

What the company does

Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products. It offers biosimilars, including Remsima for rheumatoid arthritis and inflammatory bowel disease; Truxima for non-hodgkin's lymphoma and chronic lymphocytic leukemia; Herzuma for metastatic breast and gastric cancer; Remsima SC and Yuflyma for rheumatoid arthritis and inflammatory bowel disease; Vegzelma for metastatic colorectal cancer and non-small cell lung cancer; Omlyclo for Asthma and urticaria; Eydenzelt for diabetic macular edema and wet age-related macular degeneration; Steqeyma for psoriasis and inflammatory bowel disease; Stoboclo/Osenvelt for osteoporosis; Avtozma for …

Snapshot

What the weekly tape is saying

068270 closed the latest completed week at 173,000 KRW. The 4-week return is -3.8% and the 12-week return is -14.4%. Trend Signal is inactive, Market Dynamics is -1.08. Setup signature: Risk-first tape with a 25/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -13.0%
Volume 1.0x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 35 Persistence of active Trend Signal over the last year and current streak.
Momentum 28 Blend of 4-week and 12-week follow-through.
Dynamics 29 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 43 Participation compared with the 13-week volume baseline.
Risk Control 15 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
198,930 KRW
Vs Trend Line
-13.0%
Fair Value
169,897 KRW
Vs Fair Value
1.8%
52W High
251,000 KRW
52W Low
157,740 KRW
Drawdown
-31.1%
Range Position
16.4%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.9%
4W -3.8%
12W -14.4%
26W -7.0%
52W 8.0%

Trend read

Active Streak
0 weeks
52W Active Weeks
33
52W Active Breadth
63.5%
Sector Scope
KR Healthcare
Sector Rank
20 of 63
Sector Percentile
69.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.08
4W MD Change
-17.4%
Relative Strength
-50.38
4W RS Change
-6.5%
Expectation
Undecided
Probability
47.45%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
2.9M
13W Average
2.8M
52W Average
2.9M
Vs 13W
1.0x
Vs 52W
1.0x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.2%
52W Volatility
4.7%
Upside Weeks
25
Downside Weeks
27
Downside Breadth
51.9%
Avg Gain / Loss
3.7% / -2.9%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
KSC
Country
KR
Sector
Healthcare
Industry
Biotechnology
Currency
KRW
Market Cap
41868.6B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 173,000 KRW 0.9% 198,930 KRW 169,897 KRW -1.08 -50.38 2.9M Off
5 Jun 2026 171,400 KRW -6.7% 199,673 KRW 169,748 KRW -0.93 -51.80 2.8M Off
29 May 2026 183,714 KRW -2.9% 199,699 KRW 169,631 KRW -0.79 -51.00 3.2M Off
22 May 2026 189,238 KRW 5.2% 199,404 KRW 169,461 KRW -0.85 -46.32 3.6M Off
15 May 2026 179,810 KRW -4.8% 198,836 KRW 169,253 KRW -0.92 -47.31 4.5M Off
8 May 2026 188,952 KRW -1.0% 198,651 KRW 169,111 KRW -1.03 -45.40 3.4M Off
1 May 2026 190,952 KRW -4.1% 198,115 KRW 168,867 KRW -1.14 -38.17 1.9M Off
24 Apr 2026 199,048 KRW 0.7% 197,586 KRW 168,589 KRW -1.15 -35.17 2.1M Off
17 Apr 2026 197,619 KRW 3.9% 196,859 KRW 168,246 KRW -1.04 -33.46 2.3M Off
10 Apr 2026 190,190 KRW 2.3% 195,865 KRW 167,956 KRW -0.92 -33.09 2.4M Off
3 Apr 2026 186,000 KRW -9.7% 195,225 KRW 167,758 KRW -0.68 -29.57 2.6M On
27 Mar 2026 206,000 KRW 2.0% 194,635 KRW 167,492 KRW -0.27 -23.87 2.8M On
20 Mar 2026 202,000 KRW -1.7% 193,332 KRW 167,041 KRW 0.26 -30.53 2.2M On
13 Mar 2026 205,500 KRW -3.3% 192,367 KRW 166,638 KRW 0.76 -26.46 2.6M On